Researchers in Ecuador recently claimed a 100% cure rate using intravenous chlorine dioxide against COVID-19 infection. Was this strategy truly effective? Would it be both an effective and safe clinical therapy used more widely?

Their report and their study accurately represents what has taken place. This is a disinfectant that can work in vivo and not just as a contact agent to impair microbes. It is safe to administer and can be a blessing for anyone with this illness because there will be a benefit and a reduction in severity of symptoms, resulting in a quicker recovery. It is a good example of the benefit and wisdom in having low-cost solutions that are both safe and effective. This is rarely achieved with traditional pharmaceutical agents because their chemical structures inherently cause side effects and are metabolized into often a myriad of metabolites, many of which may have properties and toxicities of their own. So there are risks and benefits, both, with traditional approaches. Chlorine dioxide is something that can be tolerated with repeated administration in reasonable amounts and can be used chronically during an infection with little risk.